News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New treatments target resistant bowel cancer
Two new drug classes appear to overcome resistance in colorectal cancer cells to one of our built in defences against the disease.
New scan could help in treatment planning for individual patients
A type of non-invasive imaging method could help assess whether cancer patients are likely to respond to radiotherapy, a new study has shown.
Of Ducks and Tumours
#CancerResearch: why aren’t we trending?
Could a fly save your life?
The answer to this seemingly absurd question is, quite definitely, yes. Now, I don’t mean that a fly is going to give you mouth-to-mouth or save you from a burning building. But if you ever have to take pharmaceutical drugs for a health condition such as cancer, it is quite possible that those drugs will have been developed with the help of research conducted using fruit flies – those same small flies that swarm around your compost heap in the summer.
Intermittent drug strategies: the new era of cancer treatment
In 2001, the Novartis drug imatinib revolutionised the treatment of chronic myeloid leukaemia, and so began a highly exciting era in cancer treatment: the era of targeted drug therapies. These differ from traditional chemotherapy drugs in their ability to knock down a specific biological pathway in a cancer cell that is essential for its malignant behaviour.
Unravelling the complexity of cancer
So… when do you think they’ll find a cure for cancer?
Illuminating myeloma
Imagine you’re in a dark room trying to solve a puzzle, but your only source of light is a narrow slit that illuminates just a single piece at a time. That might give some idea what it’s like to look for signs that a cancer has recurred for patients with myeloma, a cancer of the bone marrow.
Major study links ageing gene to blood cancer
ICR scientists find four new genetic variants linked to myeloma, including a gene called TERC, previously linked to the ageing process.
Chemotherapy reduces testicular cancer relapse and side effects
Giving men with stage 2 testicular cancer a single dose of carboplatin alongside radiotherapy could improve treatment effectiveness and reduce the risk of long-term side-effects, an ICR study reports.
ICR researchers in new international trial for neuroblastoma
New 'BEACON' trial led by ICR scientists aims to tackle treatment-resistant form of childhood cancer neuroblastoma.
Experimental breast cancer drugs could treat lung cancer too
Scientists discover that experimental drugs first developed for breast and ovarian cancer could be used to treat the most common type of lung cancer.
